Residual Solvent Analysis in Pharmaceuticals

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue

over 23 years ago

Article

Contract Services

over 23 years ago

Article

Major Changes Ahead for FDA

over 23 years ago

Article

Estimation of Distribution Coefficients from the Partition Coefficient and pKa

over 23 years ago

Article

Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Residual Solvent Analysis in Pharmaceuticals

Articles in this issue

Trending on Pharmaceutical Technology

Why Big Pharma Is Betting Billions on Protein Degraders for Cancer

Delaware Governor Meyer on Drug Pricing, Reshoring, and National Security

Renewing Prosaic Generics for Cancer Treatment

Tom Sellig on CDMO Innovation and US Manufacturing Growth

PharmTech Weekly Roundup—June 5, 2026